State statutes and regulations related to human papillomavirus vaccination

References

• U.S. Food and Drug Administration. 2006 Biological license application approvals; 2013 Apr 17 [accessed 2019 Apr 1]. http://wayback.archive-it.org/7993/20170112095308/http://www.fda.gov/BiologicsBloodVaccines/DevelopmentApprovalProcess/BiologicalApprovalsbyYear/ucm175835.htm.
   Google Scholar
• Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Mbaeyi SA, Fredua B, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2017. Morb Mortal Wkly Rep. 2018;67:909–17. doi:10.15585/mmwr.mm6733a1.
   PubMed Web of Science ®Google Scholar
• Hall MT, Simms KT, Lew J-B, Smith MA, Brotherton JML, Saville M, Frazer IH, Canfell K. The projected timeframe until cervical cancer elimination in Australia: a modelling study. Lancet Public Health. Published online. 2018 Oct 2. doi:10.1016/S2468-2667(18)30183-X.
   Web of Science ®Google Scholar
• Hirth JM, Rahman M, Smith JS, Berenson AB. Regional variations in HPV vaccination among 9–17 year old adolescent females from the BRFSS, 2008–2010. Hum Vaccin Immunother. 2014 Dec;10(12):3475–83. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514077/.
   PubMed Web of Science ®Google Scholar
• Rahman M, McGrath CJ, Berenson AB. Geographic variation in human papillomavirus vaccination uptake among 13–17 year old adolescent girls in the United States. Vaccine. 2014 May 1;32(21):2394–98. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062082/.
   PubMed Web of Science ®Google Scholar
• Thompson EL, Livingston MD, Daley EM, Zimet GD. Human papillomavirus vaccine initiation for adolescents following Rhode Island’s School-entry requirement, 2010–2016. Am J Public Health. 2018;108:1421–23. doi:10.2105/AJPH.2018.304552.
   PubMed Web of Science ®Google Scholar
• Moss JL, Reiter PL, Truong YK, Rimer BK, Brewer NT. School entry requirements and coverage of nontargeted adolescent vaccines. Pediatrics. 2016;138(6). doi:10.1542/peds.2016-1414.
   PubMed Web of Science ®Google Scholar
• Perkins RB, Lin M, Wallington SF, Hanchate AD. Impact of school-entry and education mandates by states on HPV vaccination coverage: analysis of the 2009–2013 national immunization survey-teen. Hum Vaccin Immunother. 2016;12(6):1615–22. doi:10.1080/21645515.2016.1150394.
   PubMed Web of Science ®Google Scholar
• Pierre-Victor D, Trepka MJ, Page TF, Li T, Stephens DP, Madhivanan P. Impact of Louisiana’s HPV vaccine awareness policy on HPV vaccination among 13- to 17-year-old females. Health Educ Behav. 2017;44(4):548–58. doi:10.1177/1090198116684766.
   PubMed Web of Science ®Google Scholar
• Durham DP, Ndeffo-Mbah ML, Skrip LA, Jones FK, Bauch CT, Galvani AP. National- and state-level impact and cost-effectiveness of nonavalent HPV vaccination in the United States. Proc Natl Acad Sci. 2016;113(18):5107–12. doi:10.1073/pnas.1515528113.
   PubMed Web of Science ®Google Scholar
• Roberts MC, Murphy T, Moss JL, Wheldon CW, Psek W. A qualitative comparative analysis of combined state health policies related to human papillomavirus vaccine uptake in the United States. Am J Public Health. 2018;108:493–99. doi:10.2105/AJPH.2017.304263.
   PubMed Web of Science ®Google Scholar
• National Conference of State Legislators. HPV vaccine: state legislation and statutes; 2018 Jun 12 [accessed 2018 Dec 19]. http://www.ncsl.org/research/health/hpv-vaccine-state-legislation-and-statutes.aspx.
   Google Scholar
• Immunization Action Coalition. State information: state mandates on immunization and vaccine-preventable diseases; 2018 Nov 11 [accessed 2018 Dec 19]. http://www.immunize.org/laws/.
   Google Scholar
• Dingman DA, Schmit CD. Authority of pharmacists to administer human papillomavirus vaccine: alignment of state laws with age-level recommendations. Public Health Rep. 2018;133(1):55–63. doi:10.1177/0033354917742117.
   PubMed Web of Science ®Google Scholar
• Schmit C, Reddick A Pharmacist vaccination law. The policy surveillance program: a lawAtlas project; 2016 Jan 1 [accessed 2018 Dec 19]. http://lawatlas.org/datasets/pharmacist-vaccination.
   Google Scholar
• Barraza L, Schmit C, Hoss A. The latest in vaccine policies: selected issues in school vaccinations, healthcare worker vaccinations, and pharmacist vaccination authority laws. J Law Med Ethics. 2017;45(1 suppl):16–19. doi:10.1177/1073110517703307.
   PubMed Web of Science ®Google Scholar
• Brewer NT, Chung JK, Baker HM, Rothholz MC, Smith JS. Pharmacist authority to provide HPV vaccine: novel partners in cervical cancer prevention. Gynecol Oncol. 2014;132(Supp 1):S3–S8. doi:10.1016/j.ygyno.2013.12.020.
   PubMed Web of Science ®Google Scholar
• Bayefsky MJ. The ethical case for mandating HPV vaccination. J Law Med Ethics. 2018;46:501–10. doi:10.1177/1073110518782957.
   PubMed Web of Science ®Google Scholar
• Haber G, Malow RM, Zimet GD. The HPV vaccine mandate controversy. J Pediatr Adolesc Gynecol. 2007;20:325–31. doi:10.1016/j.jpag.2007.03.101.
   PubMed Web of Science ®Google Scholar
• Vamos CA, McDermott RJ, Daley EM. The HPV vaccine: framing the argument FOR and AGAINST mandatory vaccination of all middle school girls. J School Health. 2008;78(6):302–09. doi:10.1111/j.1746-1561.2008.00306.x.
   PubMed Web of Science ®Google Scholar
• Colgrove J, Abiola S, Mello MM. HPV vaccination mandates—lawmaking amid political and scientific controversy. N Engl J Med. 2010;363:785–91. doi:10.1056/NEJMsr1003547.
   PubMed Web of Science ®Google Scholar
• Gostin LO. Mandatory HPV vaccination and political debate. Jama. 2011;306(15):1699–700. doi:10.1001/jama.2011.
   PubMed Web of Science ®Google Scholar
• Abiola SE, Colgrove J, Mello MM. The politics of HPV vaccination policy formation in the United States. J Health Politics, Policy Law. 2013;38(4):645–81. doi:10.1215/03616878-2208567.
   PubMed Web of Science ®Google Scholar
• Katz ML, Reiter PL, Kluhsman BC, Kennedy S, Dwyer S, Schoenberg N, Johnson A, Ely G, Roberto KA, Lengerich EJ, et al. Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states. Vaccine. 2009;27(24):3195–200. doi:10.1016/j.vaccine.2009.03.042.
   PubMed Web of Science ®Google Scholar
• Cook EE, Venkataramani AS, Kim JJ, Tamimi RM, Holmes MD. Legislation to increase uptake of HPV vaccination and adolescent sexual behaviors. Pediatrics. 2018;142(3). doi:10.1542/peds.2018-0458.
   Web of Science ®Google Scholar
• Keim-Malpass J, Mitchell EM, DeGuzman PB, Stoler MH, Kennedy C. Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy. Risk Manag Health Policy. 2017;10:29–32. doi:10.2147/RMHP.S128247.
   PubMed Web of Science ®Google Scholar
• Osazuwa-Peters N. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States–do we need a broader vaccine policy? Vaccine. 2013;31(47):5500–05. doi:10.1016/j.vaccine.2013.09.031.
   PubMed Web of Science ®Google Scholar
• Goodman RA, Kocher PL, O’Brien DJ, Alexander FS, “ The Structure of Law in Public Health Systems and Practice,” In: Goodman RA, Hoffman RE, Lopez W, Matthews GW, Rothstein MA, Foster KL, editors, Law in Public Health Practice. 2nd ed. 2007. p. 63.
   Google Scholar
• Centers for Disease Control and Prevention. Vaccination Laws. [accessed 2019 Apr 1]. https://www.cdc.gov/phlp/publications/topic/vaccinationlaws.html.
   Google Scholar
• Anderson E, Tremper C, Thomas S, Wagenaar AC. Measuring statutory law and regulations for empirical research. In: Burris S, Wagenaar A, editors. Public health law research: theory and methods. San Francisco, CA: Jossey-Bass; 2013. p. 237–59
   Google Scholar
• Burris S, Hitchcock L, Ibrahim J, Penn M, Ramanathan T. Policy surveillance: a vital public health practice comes of age. J Health Politics, Policy Law. 2016;41(6):1151–73. doi:10.1215/03616878-3665931.
   PubMed Web of Science ®Google Scholar
• Horwitz J, Davis CS, McClelland LS, Fordon RS, Meara E The problem of data quality in analyses of opioid regulation: the case of prescription drug monitoring programs. National Bureau of Economic Research Working Paper Series. Paper No. 24947. 2018 Aug [accessed 2019 Apr 1]. https://www.nber.org/papers/w24947.
   Google Scholar
• Burris S, Ashe M, Levin D, Penn M, Larkin M. A transdisciplinary approach to public health law: the emerging practice of legal epidemiology. Annu Rev Public Health. 2016 Mar;37:135–48. doi:10.1146/annurev-publhealth-032315-021841.
   PubMed Web of Science ®Google Scholar
• Frieden TR. A framework for public health action: the health impact pyramid. Am J Public Health. 2010;100(4):590–95. doi:10.2105/AJPH.2009.185652.
   PubMed Web of Science ®Google Scholar
• Phadke VK, Bednarczyk RK, Salmon DA, Omer SB. Association between vaccine refusal and vaccine-preventable diseases in the United States: A review of measles and pertussis. Jama. 2016;315(11):1149–58. doi:10.1001/jama.2016.1353.
   PubMed Web of Science ®Google Scholar
• Yang YT, Debold V. A longitudinal analysis of the effect of nonmedical exemption law and vaccine uptake on vaccine-targeted disease rates. Am J Public Health. 2014;104(2):371–77. doi:10.2105/AJPH.2013.301538.
   PubMed Web of Science ®Google Scholar
• Smulian EA, Mitchell KR, Stokley S. Interventions to increase HPV vaccination coverage: a systematic review. Human Vaccines Immunother. 2016;12(6):1566–88. doi:10.1080/21645515.2015.1125055.
   PubMed Web of Science ®Google Scholar
• Dutta T, Meyerson BE, Agley JD. African cervical cancer prevention and control plans: A scoping review. J Cancer Policy. 2018;16(Jun):73–81. doi:10.1016/j.jcpo.2018.05.002.
   Web of Science ®Google Scholar
• Lacombe-Duncan A, Newman PA, Baiden P. Human papillomavirus vaccine acceptability and decision-making among adolescent boys and parents: a meta-ethnography of qualitative studies. Vaccine. 2018;36(19):2545–58. doi:10.1016/j.vaccine.2018.02.079.
   PubMed Web of Science ®Google Scholar
• Meyerson BE, Zimet GD, Multani GS, Levell C, Lawrence CA, Smith JS. Increasing efforts to reduce cervical cancer through state-level comprehensive cancer control planning. Cancer Prev Res. 2015;8(7):636–41. doi:10.1158/1940-6207.CAPR-15-0004.
   PubMed Web of Science ®Google Scholar
• Daley EM, Vamos CA, Zimet GD, Rosberger Z, Thompson EL, Merrell L. The feminization of HPV: reversing gender biases in US human papillomavirus vaccine policy. Am J Public Health. 2016;106:983–84. doi:10.2105/AJPH.2016.303122.
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, Lawson HE, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014 Dec 12;63(49):1182.
   Google Scholar
• FDA. Licensure of quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). Mmwr. 2010 May 28;59(20):630–32.
   PubMedGoogle Scholar